IN8bio, Inc. (INAB) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for IN8bio, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.53x | -13.58x | -41.20x | -50.95x | -168.80x | -678.55x |
| P/B Ratio | 0.37x | 28.55x | 49.58x | 63.92x | 64.78x | 316.92x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 8.82x | 4.08x | 4.57x | 3.82x | 17.28x | 7.05x |
| Quick Ratio | 8.82x | 4.08x | 4.57x | 3.82x | 17.28x | 7.05x |
| Leverage | ||||||
| Debt/Equity | 0.10x | 0.35x | 0.20x | 0.26x | 0.06x | 0.01x |
YoY = year-over-year change. Source: FMP..